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OBJECTIVES: To investigate the association of body cell mass loss with disease activity and disability in rheumatoid
arthritis patients.
INTRODUCTION: Rheumatoid cachexia, defined as the loss of body cell mass, is important but under-recognized and
contributes to morbidity and mortality in patients with rheumatoid arthritis.
METHODS: One hundred forty-nine rheumatoid arthritis patients and 53 healthy, non-rheumatoid arthritis control
subjects underwent anthropometric measurements of body mass index and waist and hip circumferences.
Bioelectrical impedance analysis was used to determine the subjects’ body compositions, including fat mass, skeletal
lean mass, and body cell mass. The disease activity of rheumatoid arthritis was assessed using C-reactive protein
serum, the erythrocyte sedimentation rate and the 28-joint disease activity score, while disability was evaluated
using a health assessment questionnaire.
RESULTS: Rheumatoid arthritis patients had lower waist-to-hip ratio (0.86¡0.07 vs. 0.95¡0.06; p,0.001) and lower
skeletal lean mass indexes (14.44¡1.52 vs. 15.18¡1.35; p=0.002) than those in the healthy control group.
Compared with rheumatoid arthritis patients with higher body cell masses, those with body cell masses lower than
median had higher erythrocyte sedimentation rates (40.10¡27.33 vs. 25.09¡14.85; p,0.001), higher disease activity
scores (5.36¡3.79 vs. 4.23¡1.21; p=0.022) and greater disability as measured by health assessment questionnaire
scores (1.26¡0.79 vs. 0.87¡0.79; p=0.004).
CONCLUSIONS: The loss of body cell mass is associated with higher disease activity and greater disability in
rheumatoid arthritis patients. Body composition determined by bioelectrical impedance analysis can provide
valuable information for a rheumatologist to more rapidly recognize rheumatoid cachexia in rheumatoid arthritis
patients.
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INTRODUCTION
Rheumatoid cachexia affects two-thirds of rheumatoid
arthritis (RA) patients and is defined as the loss of body cell
mass (BCM), which is the fat-free component of cells within
muscle, visceral organs and the immune system, and an
often compensatory increase in fat mass (FM; i.e., cachectic
obesity).1 BCM is considered to be the most important factor
in determining energy expenditure, protein needs, and the
metabolic response to stress.2 The consequences of chronic
inflammation and increased production of cytokines,
including tumor necrosis factor (TNF)-a and interleukin
(IL)-1b, are responsible for higher resting energy turnovers
and altered body compositions in RA patients.3 Sir James
Paget described wasting of skeletal muscle mass in patients
with inflammatory arthritis that was not due to disuse
atrophy.4 The loss of BCM in various diseases, including
RA, congestive heart failure, acquired immunodeficiency
syndrome (AIDS), starvation, critical illness, and aging has
been associated with poor clinical outcomes.5 Rheumatoid
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cachexia is associated with an increased erythrocyte
sedimentation rate (ESR), C-reactive protein (CRP), func-
tional dependence, and an increased chance of morbidity
and premature mortality.6 Although the prevalence rate of
rheumatoid cachexia is high, it remains under-recognized,
partly because an abnormal body composition phenotype in
RA patients occurs most often in patients with normal body
mass indexes (BMIs).1,3,7-9 Therefore, a body composition
measurement beyond anthropometric parameters is essen-
tial to identifying RA patients with rheumatoid cachexia.
A wide range of imaging techniques have been used to
analyze the body compositions of RA patients, and dual X-
ray absorptometry (DXA) has been reported to be the most
useful tool for measuring soft tissue mass and bone mineral
density.3,6,10-12 However, DXA is not universally available,
requires a scheduled appointment and is sensitive to the
patient’s hydration status.13-15 A rapid and simple tool for
identifying rheumatoid cachexia in outpatient settings is
therefore necessary.
The abilities of different body tissues to conduct electrical
currents have been known for more than a century.16
Bioelectrical impedance analysis (BIA) has the ability to
distinguish fat tissue from fat-free tissue and water. Due to
its relatively low cost, easy operation and high portability,
BIA is probably the most commonly utilized method of
evaluating body composition.16
The present study was designed to compare the body
compositions, as measured by BIA, of RA patients with
those of healthy control subjects. The impact of RA disease
activity and disability on body composition was also
explored.
MATERIALS AND METHODS
Participants
This study included 149 patients who visited the rheumatol-
ogy clinic of Taichung Veterans General Hospital and were
diagnosed with RA according to the 1987 revised criteria of the
American College of Rheumatology (ACR).17 Patients with
terminal cancer, end-stage liver, or renal diseasewere excluded.
Fifty-three age- and gender-matched volunteers without rheu-
matic diseases were enrolled as healthy control subjects.
Anthropometric Measurements
All measurements were performed after a 12-hour over-
night fast. Participants were weighed while wearing light
clothes but no shoes. Patient heights were determined to the
nearest 0.1 cm using a fixed-wall-scale measuring device. The
weight of each subject was determined to an accuracy of 0.1 kg
using an electronic scale that was calibrated before each
measurement session. The BMI was calculated as weight (kg)
per height (m2). The waist circumference (WC) was measured
to the nearest centimeter at the level of the umbilicus after
expiration while the participant was standing still, breathing
quietly, distributing weight equally onto both feet with arms
hanging loosely at the sides and the head facing straight
ahead. The hip circumference (HC) was measured to the
nearest centimeter at the level of themaximal protrusion of the
gluteal muscles over the underwear. The waist-to-hip ratio
(WHR) was computed as WC divided by HC.
Body composition determination
The patients’ body compositions, including the FM and
the skeletal lean mass (SLM), were assessed by the InBody
720 device (Biospace Co., Korea), a multifrequency impe-
dance meter that takes readings from the body using an
eight-point tactile electrode method and measures resis-
tance at five frequencies (1 kHz, 50 kHz, 250 kHz, 500 kHz,
and 1 MHz) and reactance at three frequencies (5 kHz,
50 kHz, and 250 kHz).18-20 In accordance with the manu-
facturer’s guidelines, participants wiped the bottom of their
feet with a proprietary electrolyte tissue before standing on
the electrodes embedded into the scale platform. The
participants were instructed to stand upright and grasp
the handles of the analyzer, thereby providing contact with
a total of eight electrodes (two for each foot and hand). The
data were electronically imported into Excel using the
software Lookin’Body 3.0. The repeated FM measurements
exhibited a coefficient of variation of 0.6%. The FM index
was computed as the FM per height (m2), while the SLM
index was calculated as the SLM per height (m2). BCM was
determined according to sex-specific equations that have
previously been validated and reported.21
RA disease activity
The CRP serum levels, ESR and the 28-joint disease
activity score (DAS28)22 were utilized to assess the RA
disease activity. Low disease activity was defined as
DAS28 3.2, moderate disease activity was defined as
DAS28.3.2 but 5.1, and high disease activity was defined
as DAS28.5.1.23
Disability
The level of disability in terms of disease impact was
determined by a health assessment questionnaire (HAQ),24
which is a 20-item self-reported functional questionnaire
with items rated from 0 to 3 and increasing in steps of 0.125
units. Subjects are considered to present a disability if their
HAQ score§1.25
Ethics
This study protocol was approved by the Ethics
Committee of Clinical Research, Taichung Veterans
General Hospital, and informed consent was obtained from
each participant.
Statistical Analysis
The data in the text and tables are expressed as a
mean¡standard deviation. The software Statistical Package
for the Social Sciences (SPSS) version 13.0 (SPSS Inc.,
Chicago, IL, USA) was used to perform all statistical
analyses. Student’s t-test or the Mann-Whitney U test were
used to compare continuous variables when appropriate.
Categorical variables were compared using the chi-squared
test or Fisher’s exact test when appropriate. Associations
between variables were determined by Pearson’s correla-
tion. For all tests, a p-value ,0.05 was considered
statistically significant.
RESULTS
Demographic data, clinical characteristics,
anthropometric measurements, body composition
and comorbidities in RA patients and healthy
control subjects
As shown in Table 1, RA patients exhibit significantly
lower waist-to-hip ratios than do healthy controls
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(0.86¡0.07 vs. 0.95¡0.06, respectively; p,0.001) and exhibit
lower SLM indexes than do healthy controls (14.44¡1.52 vs.
15.18¡1.35, respectively; p= 0.002). The RA patients also
exhibited a trend towards decreased BCM compared to the
control group (24.11¡3.64 kg vs. 25.12¡3.62 kg, respec-
tively; p= 0.083), although statistical significance was not
achieved. No significant differences were observed in the
demographic data or comorbidities of the RA patients and
the healthy control subjects.
Association of body weight and BCM in RA patients
and healthy control subjects
As shown in Figure 1, body weight and BCM are
positively and significantly correlated in both RA patients
(A, correlation coefficient = 0.62; p,0.001) and healthy
control subjects (B, correlation coefficient = 0.67; p,0.001).
Comparison of clinical characteristics,
anthropometric measurements and body
compositions of RA patients with different BCM
levels
The RA group was split into two groups, with BCM values
higher or lower than the gender-stratified median BCM
values (23.4 in female and 29.2 in male participants, see
Table 2). Patients with lower BCM values were older than
were patients with higher BCM values (60.14¡11.45 years vs.
52.70¡12.59 years, respectively; p,0.001), had higher ESR
levels (40.10¡27.33 mm/hr vs. 25.09¡14.85 mm/hr, respec-
tively; p,0.001), had higher DAS28 values (5.36¡3.79 vs.
4.23¡1.21 respectively; p= =0.022), were more physically
dependent in terms of HAQ scores (1.26¡0.79 vs. 0.87¡0.79,
respectively; p= 0.004), and exhibited decreased serum
albumin levels (3.97¡0.44 vs. 4.17¡0.51, respectively;
p=0.041).
Comparison of BCMs between different disease
activity and disability in RA patients
In Figure 2A, RA patients with high disease activity had
lower BCMs than did those with moderate or low disease
activity. Moreover, RA patients with physical dependence
in terms of HAQ scores had lower BCMs than did those
without a disability (Figure 2B).
DISCUSSION
Rheumatoid cachexia, characterized by the loss of BCM,
leads to an increased chance of morbidity and premature
mortality.6 BCM has also been reported as a valuable
indicator of nutritional status, physical activity, and RA
disease activity, making it a powerful predictor of outcome
in various disease entities, including RA, critical illness,
starvation, and aging.26,27 Anthropometric measurements
including body weight and BMI, although useful in
predicting disease activity and survival in RA patients, are
not sensitive to the changes in body composition that occur
with aging and chronic inflammation.6 Therefore, it is
important to analyze body composition using tools beyond
simply measuring body weight and BMI to evaluate the
impact of chronic inflammation in each individual.28 The
present study is the first attempt to measure FM, SLM, and
BCM, which are surrogate markers of rheumatoid cachexia,
in RA patients of Asian ethnicity using BIA technology,
which is quick and easy to deploy in the outpatient setting
of rheumatology clinics.
Table 1 - Demographic data, comorbidities and body
compositions of 149 patients with rheumatoid arthritis
(RA) and 53 unrelated healthy control subjects (HC)#.
Factors RA (n=149) HC (n=53)
Age at study entry (years) 56.68¡12.52 60.11¡8.94
Gender (male, %) 18 (12.1) 7 (13.2)
BMI (kg/m2) 24.08¡4.23 25.20¡3.46
WC (cm) 79.72¡10.28 88.04¡9.84**
HC (cm) 92.94¡8.55 92.38¡7.10
Waist-to-hip ratio 0.86¡0.07 0.95¡0.06**
ESR (mm/hr) 33.12¡23.56 NA
CRP (mg/dl) 1.60¡9.09 NA
DAS28 4.84¡2.96 NA
HAQ 1.08¡0.81 NA
FM (kg) 21.37¡8.26 21.63¡6.46
FM index (kg/m2) 8.79¡3.53 9.06¡3.01
SLM (kg) 35.40¡5.21 36.70¡5.23
SLM index (kg/m2) 14.44¡1.52 15.18¡1.35**
BCM (kg) 24.11¡3.64 25.12¡3.62
DM 6 (4.1) 4 (7.5)
Hypertension 54 (37.2) 17 (32.1)
Smoking 11 (7.6) 2 (3.8)
#Data are presented as mean¡SD or number (percentage); NA: not
applicable;
BMI: body mass index; WC: waist circumference; HC: hip circumference;
WHR: waist-to-hip ratio; ESR: erythrocyte sedimentation rate; CRP: C-
reactive protein; DAS28: 28-joint disease activity score; HAQ: health
assessment questionnaire; FM: fat mass; SLM: skeletal lean mass; DM:
diabetes mellitus.
**p,0.001, HC versus RA patients, determined by independent sample
t-test or chi-squared test.
Figure 1 - Linear correlation between body cell mass (BCM) and
body weight in (A) 149 RA patients (correlation coeffi-
cient = 0.62, p,0.001) and (B) 53 healthy control subjects,
(correlation coefficient = 0.67, p,0.001) as determined by
Pearson’s correlation.
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Investigations of differences in the body compositions of
RA patients and healthy control subjects are inconclusive in
the literature.6 Our results and those of previous studies
found no difference in the BMI values of RA patients and
healthy control subjects.3,7 The loss of lean bodymass or BCM
in RA patients has previously been measured using a variety
of techniques, including anthropometric measurements,
DXA, and potassium-40.3,7,29 The increased prevalence of
skeletal mass loss and fat mass gain in RA patients is related
to joint deformity, physical inactivity, and poor clinical
outcomes.9 Therefore, it is crucial to recognize abnormal
body composition phenotypes as early as possible. By using
BIA, a simple and reliable body composition measurement,
our study observed reduced SLM indexes and BCM values in
RA patients when compared with healthy control subjects.
Whether FM is increased or not in RA patients has been
controversial in the past. A non-significant increase in fat
mass has been reported in previous studies,29 while
Roubenoff et al reported a reduction in FM.7 However,
Stavropoulos-Kalinoglou et al found that at a given BMI, RA
patients exhibited higher proportions of body FM than
healthy control subjects.30 In the present study, the FMs of
the RA group and the healthy control group were indis-
tinguishable. The diverse results regarding fat mass in RA
patients may be due to the different ethnicities, patient
characteristics, and methods of measurement used in
different studies.
The central pathogenesis of RA involves chronic inflam-
mation due to overproduction of the inflammatory cytokines
TNF-a and IL-1b, which are also critical to whole body
protein degradation and muscle wasting.1 Significant corre-
lations have been reported between rheumatoid cachexia and
disease activity, including the number of swollen joints, CRP
and ESR.7 Our results demonstrate a significant association
among the loss of BCM observed through BIA, the ESR and
the DAS28, one of the most commonly utilized scoring
systems for evaluating RA disease activity.22
In RA, functional limitations to daily activity originate
mainly from joint pain, swelling, and deformity.31 However,
decreased SLM may contribute to a substantial loss of
muscle strength and endurance and result in decreased
manual dexterity, difficulty in locomotion, reduced work
productivity, and impaired quality of life.32 A recent study
exploring the association between body composition and
disability in RA provided the valuable finding that loss of
SLM in the arms and legs is strongly linked to functional
limitation.33 In the present study, we found that in Chinese
Table 2 - Comparison of clinical characteristics,
anthropometric measurements and body compositions of
RA patients with diffebody cell mass (BCM) levels#.
BCM,median (n= 79) BCM § median (n= 70)
Age (years) 60.14 ¡11.45
9 (11.4)
21.86¡2.36
0.87¡0.08
40.10¡27.33
0.75¡1.39
5.36¡3.79
1.26¡0.79
3.97¡0.44
23.11¡3.75
19.77¡7.05
8.44¡3.21
32.22¡3.39
13.66¡1.10
6.09¡2.39
54 (68.4)
52.70¡12.59**
9 (12.9)
26.65¡3.13**
0.89¡0.07
25.09¡14.85**
0.44¡0.81
4.23¡1.21*
0.87¡0.79*
4.17¡0.51*
25.18¡4.50*
23.17¡9.15*
9.19¡3.85
38.98¡4.53**
15.32¡1.45**
5.64¡3.05
41 (62.1)
Male (n, %)
BMI (kg/m2)
WHR
ESR (mm/hr)
CRP (mg/dl)
DAS28
HAQ
Albumin (mg/dl)
BCM (kg)
FM (kg)
FM index
SLM
SLM index
Prednisolone (mg/day)
TNF-a inhibitors (n, %)
DM 2 (2.5) 4 (5.7)
Hypertension 33 (41.7) 21 (30.0)
Smoking 5 (6.3) 6 (8.6)
#Data are presented as mean¡SD or number (percentage).
RA: rheumatoid arthritis; BCM: body cell mass; BMI: body mass index;
WHR: waist-to-hip ratio; ESR: erythrocyte sedimentation rate; CRP: C-
reactive protein; DAS28: 28-joint disease activity score; HAQ: health
assessment questionnaire; FM: fat mass; SLM: skeletal lean mass; TNF-a
inhibitors: tumor necrosis factor-a inhibitors;
DM: diabetes mellitus.
The median BCM values were 23.4 and 29.2 in females and males,
respectively.
*p,0.05,
**p,0.001, BMC,median vs. BCM§ median RA patients, p-values.
determined by independent sample t-test or chi-squared test.
Figure 2 - (A) Comparisons of body cell mass (BCM) values of RA
patients with low, moderate and high levels of disease activity by
analysis of variance. (B) Comparisons of BCM values of RA
patients with and without disability by independent sample t-
test. Values are presented as box-plot diagrams, with the box
encompassing the range from the 25th percentile (lower bar) to
the 75th percentile (upper bar). The horizontal line within the
box indicates the median value, and the horizontal lines above
and below the box represent the maximum and minimum values,
respectively, for each group.
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RA patients, loss of BCM is significantly associated with
disability in terms of HAQ scores.
Cigarette smoking has been demonstrated to increase the
rest energy expenditure of RA patients, which could
potentiate rheumatoid cachexia in these patients.34
Moreover, smoking has been reported to be associated with
reduced BMI and body fat, while heavy smoking has been
linked with lower muscle mass in RA patients.35 In our
study, the fraction of smokers among the RA patients
appeared to be higher than that of the healthy control
subjects (7.6% vs. 3.8%, respectively), although statistical
significance was not achieved. The higher proportion of
smokers could partly explain the decreased SLM indexes of
RA patients. However, there was no difference in the
number of participants with higher and lower BCM values.
This study does have some limitations. First, the study
design was cross-sectional, which may limit the applic-
ability of the results. However, the study results demon-
strated close associations between BIA-derived body
composition parameters and several clinical variables in
RA patients. Second, body compositions were assessed by
BIA, a method that has not been specifically validated in the
RA population. Nevertheless, BIA provides a rapid and
simple way to identify patients at risk of rheumatoid
cachexia in outpatient settings. Third, this study was an
observational investigation, and the effects of appropriate
intervention for rheumatoid cachexia remain to be eluci-
dated. Therefore, a prospective, controlled study with
intervention programs is needed.
CONCLUSIONS
Loss of BCM is associated with disease activity and
disability in Chinese RA patients. BIA may be a quick,
convenient and inexpensive tool to assess body composition
and facilitate early recognition of rheumatoid cachexia by
rheumatologists during everyday clinical practice.
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